Skip to Main Content

Paper Details

ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoprotein.
Mol Oncol
1
2023
ABCB1, ERBB, ERBB family, ERRB4, P, P-glycoprotein, P-gp, afatinib, gp, high, high-risk neuroblastomas, neuroblastoma, neuroblastoma cell lines, neuroblastoma cells, patient, relapsed, sensitized cells, tariquidar, trypan blue, vincristine, zebrafish
Author NameAffiliation
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Olaf WittUniversity Hospital Heidelberg
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Olaf WittUniversity Hospital Heidelberg
  • 1 - 10

Datasets

Release 1.2